Neurotoxin-related research: from the laboratory to the clinic. - Wikidata - wikimedia - TriplyDB

Neurotoxin-related research: from the laboratory to the clinic.

Neurotoxin-related research: from the laboratory to the clinic.

http://www.wikidata.org/entity/Q35260764

about

Phase 2 study of sodium phenylbutyrate in ALS.

P2860

Q46439340-7F39E175-E688-4717-9852-71C408F54501

P2860

Neurotoxin-related research: from the laboratory to the clinic.

http://www.wikidata.org/entity/Q35260764

description

1992 nî lūn-bûn

@nan

1992 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

Neurotoxin-related research: from the laboratory to the clinic.

@ast

Neurotoxin-related research: from the laboratory to the clinic.

@en

type

label

Neurotoxin-related research: from the laboratory to the clinic.

@ast

Neurotoxin-related research: from the laboratory to the clinic.

@en

prefLabel

Neurotoxin-related research: from the laboratory to the clinic.

@ast

Neurotoxin-related research: from the laboratory to the clinic.

@en

P1433

Q35260764-A91E1F3E-0C2E-4E41-AF22-BB1AED3F2D9C

P1476

Q35260764-F9116A80-19D3-491D-8D16-06430DBF8B61

P2093

Q35260764-1B5BFBC0-6B81-49A6-98EB-D540073FE488

Q35260764-590B837C-49DA-4158-8A00-260C57C70EAD

Q35260764-7C51126E-CCE6-4618-83E6-8A72C61A49AB

Q35260764-7E364074-8A94-459F-AE5B-85963FB5B062

Q35260764-7F14AA4E-42A2-4189-944A-6B39E9B417B5

Q35260764-8D0B6EAB-3477-4364-AB96-7E19FDEFD329

Q35260764-C2E0B187-E768-45DB-9274-A9FBA02C1BA0

Q35260764-CA45176E-7542-45FA-B5D8-9351E0724A38

Q35260764-D036054B-DFBD-4C64-9CA3-B66A0E869C77

Q35260764-E862EC63-576A-41E0-82B3-384A07D5B96C

P2860

Q35260764-092009F8-FF0E-416A-9F38-97A2CEC9F102

Q35260764-2ACEB21C-0BB9-4545-9503-EEE618F65F14

Q35260764-2BBC11BB-BEE2-42D8-A426-D425FB1A0B02

Q35260764-57D4CE99-A2E7-44FC-8B1C-15FE85A34AFD

Q35260764-5C105993-FBE4-41AF-BCA4-57BB231493AD

Q35260764-5D03D263-B07D-4EAC-BF65-6EE82CE4B16C

Q35260764-6B544910-B4B9-41F5-9939-5CCD811CFB6A

Q35260764-8DD16C7C-48E5-4AB1-B8E5-EC5446AEFECD

Q35260764-A63B7A74-670D-45BA-914F-F62D25AD887E

Q35260764-D0CB427E-2ABC-4D7D-9C05-C7B78127A0D5

P304

Q35260764-F179C44B-E515-4F34-B31B-AB3CF20CE605

P31

Q35260764-AD1F01A9-EA51-4E12-8FD8-B8B2843A8652

P356

Q35260764-7A442857-2AB7-48A7-9431-47AF9FF28BCF

P407

Q35260764-10F5D920-E4FB-4055-A23B-3E67C1D135ED

P478

Q35260764-BE7AEF5D-B992-4F7D-8BF9-61064BBF559C

P577

Q35260764-FFEA5B59-D25A-4B2B-BD71-C7D906F7C1B7

P698

Q35260764-84EBE724-F2A9-448A-8D99-685E0E991F90

P356

J.1749-6632.1992.TB24540.X

P1433

Annals of the New York Academy of Sciences

P1476

Neurotoxin-related research: from the laboratory to the clinic.

@en

P2093

Foster AC

http://www.w3.org/2001/XMLSchema#string

Hill RG

http://www.w3.org/2001/XMLSchema#string

Iversen L

http://www.w3.org/2001/XMLSchema#string

Iversen SD

http://www.w3.org/2001/XMLSchema#string

Kemp JA

http://www.w3.org/2001/XMLSchema#string

Leeson PD

http://www.w3.org/2001/XMLSchema#string

Rupniak NM

http://www.w3.org/2001/XMLSchema#string

Saywell K

http://www.w3.org/2001/XMLSchema#string

Tricklebank MD

http://www.w3.org/2001/XMLSchema#string

Williams BJ

http://www.w3.org/2001/XMLSchema#string

P2860

Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex

1-Hydroxy-3-amino-pyrrolidone-2(HA-966): a new GABA-like compound, with potential use in extrapyramidal diseases.

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion

Autoradiographic assessment of the effects of N-methyl-D-aspartate (NMDA) receptor antagonists in vivo.

Noncompetitive excitatory amino acid receptor antagonists.

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists.

Effects of NG-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats

P304

207-218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1749-6632.1992.TB24540.X

http://www.w3.org/2001/XMLSchema#string

P407

P478

648

http://www.w3.org/2001/XMLSchema#string

P577

1992-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1353328

http://www.w3.org/2001/XMLSchema#string